Sign In
Buy LH
$309.20
-6.33 (-2.01%)
At Close: Jul 31, 2026
Labcorp Holdings Inc. $LH Position Cut by Brandes Investment Partners LP
04:36am, Tuesday, 02'nd Dec 2025
Brandes Investment Partners LP reduced its holdings in Labcorp Holdings Inc. (NYSE: LH) by 57.6% during the undefined quarter, according to the company in its most recent filing with the Securities an
Advisors Asset Management Inc. Buys 770 Shares of Labcorp Holdings Inc. $LH
03:14am, Monday, 01'st Dec 2025
Advisors Asset Management Inc. grew its stake in Labcorp Holdings Inc. (NYSE: LH) by 19.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commis
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue?
12:31pm, Thursday, 27'th Nov 2025
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 25'th Nov 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Appoints Victor Bulto to Board of Directors
08:30am, Monday, 24'th Nov 2025
Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategy BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp (NYSE:
Cetera Investment Advisers Lowers Stock Position in Labcorp Holdings Inc. $LH
04:38am, Monday, 24'th Nov 2025
Cetera Investment Advisers lessened its holdings in Labcorp Holdings Inc. (NYSE: LH) by 1.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Ex
LH Shares Gain Following Publication of New Plasma Detect MRD Data
09:16am, Friday, 21'st Nov 2025
Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
07:04am, Wednesday, 19'th Nov 2025
Studies demonstrate Labcorp Plasma Detect MRD Technology can inform treatment strategies and advance cancer research BURLINGTON, N.C. , Nov. 19, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global le
Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research
09:00am, Monday, 17'th Nov 2025
DURHAM, N.C. and SEOUL, South Korea , Nov. 17, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and compre
World Investment Advisors Takes Position in Labcorp Holdings Inc. $LH
03:47am, Wednesday, 05'th Nov 2025
World Investment Advisors purchased a new stake in shares of Labcorp Holdings Inc. (NYSE: LH) during the second quarter, according to the company in its most recent filing with the Securities and Exch
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
02:45pm, Tuesday, 28'th Oct 2025
Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18.
Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript
12:31pm, Tuesday, 28'th Oct 2025
Labcorp Holdings Inc. (NYSE:LH ) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Christin O'Donnell - Vice President of Investor Relations Adam Schechter - President, CEO & Cha
LH Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
11:06am, Tuesday, 28'th Oct 2025
Labcorp's Q3 earnings beat forecasts and margins improve, but a trimmed 2025 sales outlook sends shares down.
Here's Why Labcorp Holdings (LH) is a Strong Growth Stock
10:46am, Tuesday, 28'th Oct 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp (LH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
10:30am, Tuesday, 28'th Oct 2025
While the top- and bottom-line numbers for Labcorp (LH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare
